Cerebrolysin vs Glycine Peptide
Overview
Cerebrolysin is primarily a pain management peptide, while Glycine Peptide is used for sleep & recovery.
This page compares Cerebrolysin and Glycine Peptide across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.
Side-by-side comparison
| Cerebrolysin | Glycine Peptide | |
|---|---|---|
| Category | Pain Management | Sleep & Recovery |
| Regulatory status (US) | Research use only | Research use only |
| Typical dosage | 5-10 ml | 3-5 g |
| Frequency | multiple weekly | before bed |
| Reported benefits | Nerve pain reduction, neuroprotection, stroke pain support | Improved sleep quality, faster sleep onset, better morning alertness |
| Reported side effects | Generally well-tolerated | Very safe |
Key differences
Primary use. Cerebrolysin is categorised under Pain Management, while Glycine Peptide falls under Sleep & Recovery. Their differing categories mean they are usually chosen for different goals rather than as direct substitutes.
Regulatory status. Cerebrolysin: not FDA-approved; treated as a research compound. Glycine Peptide: not FDA-approved; treated as a research compound.
Dosing. Cerebrolysin is typically dosed at 5-10 ml (multiple weekly). Glycine Peptide is typically dosed at 3-5 g (before bed).
Can you stack them?
Some protocols combine peptides, but stacking Cerebrolysin and Glycine Peptide has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.
Frequently asked questions
- What is the difference between Cerebrolysin and Glycine Peptide?
- Cerebrolysin is primarily a pain management peptide, while Glycine Peptide is used for sleep & recovery. Cerebrolysin is not FDA-approved; generally classified as a research compound, whereas Glycine Peptide is not FDA-approved; generally classified as a research compound.
- What is Cerebrolysin used for?
- Neuropathic pain support.
- What is Glycine Peptide used for?
- Sleep quality amino peptide.
- Can you take Cerebrolysin and Glycine Peptide together?
- Some users combine peptides within a single protocol, but stacking Cerebrolysin and Glycine Peptide has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.
- Is Cerebrolysin or Glycine Peptide FDA-approved?
- Cerebrolysin is not FDA-approved; generally classified as a research compound. Glycine Peptide is not FDA-approved; generally classified as a research compound.
Read the full articles
- Cerebrolysin — full monograph: mechanism, research, dosing & references
- Glycine Peptide — full monograph: mechanism, research, dosing & references